Icahn Enterprises L.P. (Nasdaq: IEP) Today Announced Its Fourth Quarter and Full Year 2025 Financial Results
Rhea-AI Summary
Icahn Enterprises (Nasdaq: IEP) reported Q4 2025 Adjusted EBITDA of $281 million versus $16 million in Q4 2024 and Q4 2025 net income attributable to IEP of $1 million versus a $98 million loss a year earlier.
For FY2025, revenues were $9.7 billion with a net loss of $299 million and Adjusted EBITDA of $338 million. Indicative NAV was approximately $3.2 billion, down $654 million from Sept. 30, 2025, driven mainly by a $778 million decrease in the CVI long position and $75 million of Holding Company net interest expense. The board declared a $0.50 quarterly distribution payable about April 15, 2026.
Positive
- Q4 Adjusted EBITDA increased to $281 million (Q4 2024: $16 million)
- FY Adjusted EBITDA rose to $338 million from $184 million year-over-year
- Q4 net income of $1 million vs. a $98 million loss in Q4 2024
Negative
- Indicative NAV declined by $654 million since Sept. 30, 2025
- CVI long position decreased by $778 million, driving NAV decline
- Cash and equivalents fell to $1.45 billion from $2.60 billion year-over-year
- Depositary units outstanding increased ~22% to 637.2 million, diluting LP unit basis
Key Figures
Market Reality Check
Peers on Argus
Sector peers were mixed: CVI up 3.28%, PBF up 4.09%, while SUN and DKL were slightly negative and DINO was modestly positive. Momentum scans flagged only PARR down 11.72%, suggesting today’s action in IEP is more company-specific than a broad refining move.
Previous Earnings Reports
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Nov 05 | Q3 2025 earnings | Positive | +8.9% | Stronger Q3 results with higher net income, EBITDA and indicative NAV. |
| Aug 04 | Q2 2025 earnings | Positive | -0.3% | Improved loss, higher revenue and rising indicative NAV but modest price dip. |
| May 07 | Q1 2025 earnings | Negative | -4.2% | Large net loss, revenue decline and reduced indicative NAV with cut distribution. |
| Feb 26 | Q4 2024 earnings | Negative | -2.2% | Ongoing net loss and indicative NAV decline despite modest EBITDA improvement. |
| Nov 08 | Q3 2024 earnings | Negative | -6.1% | Distribution cut, lower EBITDA and reduced indicative NAV drove selling. |
Earnings releases have often coincided with negative or mixed price reactions, even when results improved. Only Q3 2025 produced a strong positive move; other earnings reports in 2024–2025 tended to see selling pressure following announcements.
Over the past five earnings cycles, Icahn Enterprises moved from recurring losses and declining indicative net asset value in late 2024 and early 2025 to a markedly stronger Q3 2025, which showed higher net income, improved Adjusted EBITDA and a higher indicative net asset value of $3.8 billion. Distributions were cut from $1.00 to $0.50 per unit and then maintained. Today’s Q4/FY 2025 report continues that narrative of operational recovery but against a backdrop of historically cautious market reactions.
Historical Comparison
Across the last five earnings announcements, IEP’s average next-day move was -0.81%, with only Q3 2025 generating a strong positive reaction, suggesting markets often react cautiously to its results.
Earnings from late 2024 through 2025 show a path from recurring losses and NAV declines to improving quarterly performance and a stabilized $0.50 distribution, highlighted by a notably strong Q3 2025.
Market Pulse Summary
This announcement highlights a strong Q4 2025 rebound, with Adjusted EBITDA at $281 million and net income turning slightly positive, while full‑year 2025 still reflects a $299 million net loss and softer $9.7 billion revenue. Indicative net asset value of roughly $3.2 billion fell $654 million from September 30, 2025. Investors may watch future earnings, NAV trends, segment performance, and the sustainability of the $0.50 distribution for confirmation of a durable recovery.
Key Terms
adjusted ebitda financial
master limited partnership financial
non-gaap financial
ebitda financial
forward-looking statements regulatory
investment company act of 1940 regulatory
AI-generated analysis. Not financial advice.
- Q4 2025 Adjusted EBITDA was
, compared to Adjusted EBITDA of$281 million in Q4 2024$16 million - Q4 2025 net income attributable to IEP was
, compared to a net loss of$1 million in Q4 2024$98 million - IEP declares fourth quarter distribution of
per depositary unit$0.50 - Indicative Net Asset Value was approximately
as of December 31, 2025, a decrease of$3.2 billion compared to September 30, 2025. The decrease was primarily due to a decrease of$654 million of our long position in CVI and the Holding Company's net interest expense of$778 million . The decrease was offset in part by the positive performance from the Funds of$75 million $261 million
Financial Summary
(Net income, net loss and Adjusted EBITDA figures in commentary below are attributable to Icahn Enterprises, unless otherwise specified)
For the three months ended December 31, 2025, revenues were
For the year ended December 31, 2025, revenues were
As of December 31, 2025, indicative net asset value decreased
On February 23, 2026, the Board of Directors of the general partner of Icahn Enterprises declared a quarterly distribution in the amount of
Icahn Enterprises L.P., a master limited partnership, is a diversified holding company owning subsidiaries currently engaged in the following continuing operating businesses: Investment, Energy, Automotive, Food Packaging, Real Estate, Home Fashion and Pharma.
Caution Concerning Forward-Looking Statements
This release may contain certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, many of which are beyond our ability to control or predict. Forward-looking statements may be identified by words such as "expects," "anticipates," "intends," "plans," "believes," "seeks," "estimates," "will" or words of similar meaning and include, but are not limited to, statements about the expected future business and financial performance of Icahn Enterprises and its subsidiaries. Actual events, results and outcomes may differ materially from our expectations due to a variety of known and unknown risks, uncertainties and other factors, including risks related to economic downturns, substantial competition and rising operating costs; risks related to our investment activities, including the nature of the investments made by the private funds in which we invest, including the impact of the use of leverage through options, short sales, swaps, forwards and other derivative instruments; risks related to our ability to comply with the covenants in our senior notes and the risk of foreclosure on the assets securing our notes; declines in the fair value of our investments, losses in the private funds and loss of key employees; risks related to our ability to continue to conduct our activities in a manner so as to not be deemed an investment company under the Investment Company Act of 1940, as amended, or to be taxed as a corporation; risks related to short sellers and associated litigation and regulatory inquiries; risks relating to our general partner and controlling unitholder; pledges of our units by our controlling unitholder; risks related to our energy business, including the volatility and availability of crude oil, other feed stocks and refined products, declines in global demand for crude oil, refined products and liquid transportation fuels, unfavorable refining margin (crack spread), interrupted access to pipelines, significant fluctuations in nitrogen fertilizer demand in the agricultural industry and seasonality of results; volatile commodity pricing and higher industry utilization and oversupply risks related to potential strategic transactions involving our Energy segment, and the impact of tariffs; risks related to our automotive activities and exposure to adverse conditions in the automotive industry, including as a result of the Chapter 11 filing of our automotive parts subsidiary; risks related to our food packaging activities, including competition from better capitalized competitors, inability of our suppliers to timely deliver raw materials, and the failure to effectively respond to industry changes in casings technology; supply chain issues; inflation, including increased costs of raw materials and shipping; interest rate increases; labor shortages and workforce availability; risks related to our real estate activities, including the extent of any tenant bankruptcies and insolvencies; risks related to our home fashion operations, including changes in the availability and price of raw materials, manufacturing disruptions, and changes in transportation costs and delivery times; the impacts from the ongoing
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS | |||||||||||
Three Months Ended | Year Ended | ||||||||||
2025 | 2024 | 2025 | 2024 | ||||||||
(in millions, except per unit amounts) | |||||||||||
Revenues: | |||||||||||
Net sales | $ | 2,170 | $ | 2,366 | $ | 8,631 | $ | 9,193 | |||
Other revenues from operations | 156 | 141 | 664 | 707 | |||||||
Net gain (loss) from investment activities | 333 | (103) | (183) | (421) | |||||||
Interest and dividend income | 66 | 97 | 288 | 477 | |||||||
(Loss) gain on disposition of assets, net | (15) | 2 | 247 | (4) | |||||||
Other (loss) income, net | (13) | 55 | 11 | 68 | |||||||
2,697 | 2,558 | 9,658 | 10,020 | ||||||||
Expenses: | |||||||||||
Cost of goods sold | 2,159 | 2,205 | 7,978 | 8,619 | |||||||
Other expenses from operations | 144 | 141 | 599 | 603 | |||||||
Selling, general and administrative | 211 | 205 | 837 | 783 | |||||||
Dividend expense | 10 | 9 | 35 | 56 | |||||||
Restructuring, net | 3 | 2 | 10 | 3 | |||||||
Impairment | 28 | — | 40 | — | |||||||
Interest expense | 125 | 129 | 504 | 523 | |||||||
2,680 | 2,691 | 10,003 | 10,587 | ||||||||
Income (loss) before income tax benefit | 17 | (133) | (345) | (567) | |||||||
Income tax benefit | 27 | 23 | 19 | 25 | |||||||
Net income (loss) | 44 | (110) | (326) | (542) | |||||||
Less: net income (loss) attributable to non-controlling interests | 43 | (12) | (27) | (97) | |||||||
Net income (loss) attributable to Icahn Enterprises | $ | 1 | $ | (98) | $ | (299) | $ | (445) | |||
Net gain (loss) attributable to Icahn Enterprises allocated to: | |||||||||||
Limited partners | $ | 1 | $ | (96) | $ | (293) | $ | (436) | |||
General partner | — | (2) | (6) | (9) | |||||||
1 | (98) | (299) | (445) | ||||||||
Basic and Diluted income (loss) per LP unit | $ | 0.00 | $ | (0.19) | $ | (0.52) | $ | (0.94) | |||
Basic and diluted weighted average LP units outstanding | 605 | 505 | 562 | 466 | |||||||
Distributions declared per LP unit | $ | 0.50 | $ | 0.50 | $ | 2.00 | $ | 3.50 | |||
CONDENSED CONSOLIDATED BALANCE SHEETS | ||||||
December 31, | ||||||
2025 | 2024 | |||||
(in millions, except unit amounts) | ||||||
ASSETS | ||||||
Cash and cash equivalents | $ | 1,450 | $ | 2,603 | ||
Cash held at consolidated affiliated partnerships and restricted cash | 1,969 | 2,636 | ||||
Investments | 2,251 | 2,310 | ||||
Due from brokers | 1,656 | 1,624 | ||||
Accounts receivable, net | 393 | 479 | ||||
Related party notes receivable, net | 129 | 7 | ||||
Inventories | 845 | 897 | ||||
Property, plant and equipment, net | 3,670 | 3,843 | ||||
Deferred tax asset | 165 | 160 | ||||
Derivative assets, net | 7 | 22 | ||||
Goodwill | 290 | 288 | ||||
Intangible assets, net | 349 | 409 | ||||
Assets held for sale | — | 25 | ||||
Other assets | 1,041 | 976 | ||||
Total Assets | $ | 14,215 | $ | 16,279 | ||
LIABILITIES AND EQUITY | ||||||
Accounts payable | $ | 690 | $ | 802 | ||
Accrued expenses and other liabilities | 1,192 | 1,547 | ||||
Deferred tax liabilities | 314 | 331 | ||||
Derivative liabilities, net | 595 | 756 | ||||
Securities sold, not yet purchased, at fair value | 1,382 | 1,373 | ||||
Due to brokers | — | 40 | ||||
Debt | 6,616 | 6,809 | ||||
Total liabilities | 10,789 | 11,658 | ||||
Equity: | ||||||
Limited partners: Depositary units: 637,209,452 units issued and outstanding at December 31, 2025 and 522,736,315 units issued and outstanding at December 31, 2024 | 2,728 | 3,241 | ||||
General partner | (786) | (775) | ||||
Equity attributable to Icahn Enterprises | 1,942 | 2,466 | ||||
Equity attributable to non-controlling interests | 1,484 | 2,155 | ||||
Total equity | 3,426 | 4,621 | ||||
Total Liabilities and Equity | $ | 14,215 | $ | 16,279 | ||
Use of Non-GAAP Financial Measures
The Company uses certain non-GAAP financial measures in evaluating its performance. These include non-GAAP EBITDA and Adjusted EBITDA. EBITDA represents earnings from continuing operations before net interest expense (excluding our Investment Segment), income tax (benefit) expense and depreciation and amortization. We define Adjusted EBITDA as EBITDA excluding certain effects of impairment, restructuring costs, transformation costs, certain pension plan expenses, gains/losses on disposition of assets, gains/losses on extinguishment of debt, the performance of closed stores and including closing costs, and certain other non-operational or non-recurring charges. We present EBITDA and Adjusted EBITDA on a consolidated basis and on a basis attributable to Icahn Enterprises net of the effects of non-controlling interests. We conduct substantially all of our operations through subsidiaries. The operating results of our subsidiaries may not be sufficient to make distributions to us. In addition, our subsidiaries are not obligated to make funds available to us for payment of our indebtedness, payment of distributions on our depositary units or otherwise, and distributions and intercompany transfers from our subsidiaries to us may be restricted by applicable law or covenants contained in debt agreements and other agreements to which these subsidiaries currently may be subject or into which they may enter into in the future. The terms of any borrowings of our subsidiaries or other entities in which we own equity may restrict dividends, distributions or loans to us.
We believe that providing EBITDA and Adjusted EBITDA to investors has economic substance as these measures provide important supplemental information of our performance to investors and permits investors and management to evaluate the core operating performance of our business without regard to interest (except with respect to our Investment segment), taxes and depreciation and amortization and certain effects of impairment, restructuring costs, certain pension plan expenses, gains/losses on disposition of assets, gains/losses on extinguishment of debt and certain other non-operational charges. Additionally, we believe this information is frequently used by securities analysts, investors and other interested parties in the evaluation of companies that have issued debt. Management uses, and believes that investors benefit from referring to, these non-GAAP financial measures in assessing our operating results, as well as in planning, forecasting and analyzing future periods. Adjusting earnings for these charges allows investors to evaluate our performance from period to period, as well as our peers, without the effects of certain items that may vary depending on accounting methods and the book value of assets. Additionally, EBITDA and Adjusted EBITDA present meaningful measures of performance exclusive of our capital structure and the method by which assets were acquired and financed.
EBITDA and Adjusted EBITDA have limitations as analytical tools, and you should not consider them in isolation, or as substitutes for analysis of our results as reported under generally accepted accounting principles in
- do not reflect our cash expenditures, or future requirements for capital expenditures, or contractual commitments;
- do not reflect changes in, or cash requirements for, our working capital needs; and
- do not reflect the significant interest expense, or the cash requirements necessary to service interest or principal payments on our debt.
Although depreciation and amortization are non-cash charges, the assets being depreciated or amortized often will have to be replaced in the future, and EBITDA and Adjusted EBITDA do not reflect any cash requirements for such replacements. Other companies in the industries in which we operate may calculate EBITDA and Adjusted EBITDA differently than we do, limiting their usefulness as comparative measures. In addition, EBITDA and Adjusted EBITDA do not reflect the impact of earnings or charges resulting from matters we consider not to be indicative of our ongoing operations.
EBITDA and Adjusted EBITDA are not measurements of our financial performance under
Use of Indicative Net Asset Value Data
The Company uses indicative net asset value as an additional method for considering the value of the Company's assets, and we believe that this information can be helpful to investors. Please note, however, that the indicative net asset value does not represent the market price at which the depositary units trade. Accordingly, data regarding indicative net asset value is of limited use and should not be considered in isolation.
The Company's depositary units are not redeemable, which means that investors have no right or ability to obtain from the Company the indicative net asset value of units that they own. Units may be bought and sold on The Nasdaq Global Select Market at prevailing market prices. Those prices may be higher or lower than the indicative net asset value of the depositary units as calculated by management.
See below for more information on how we calculate the Company's indicative net asset value.
December 31, | September 30, | December 31, | |||
2025 | 2025 | 2024 | |||
(in millions)(unaudited) | |||||
Market-valued Subsidiaries and Investments: | |||||
Holding Company interest in Investment Funds(1) | |||||
CVR Energy(2) | 1,791 | 2,569 | 1,250 | ||
CVR Partners LP(2) | 28 | 25 | 13 | ||
Total market-valued subsidiaries and investments | |||||
Other Subsidiaries: | |||||
Viskase(3) | |||||
Real Estate Segment(4) | 1,367 | 692 | 743 | ||
WestPoint Home(1) | 155 | 159 | 162 | ||
Vivus(1) | 169 | 183 | 209 | ||
Icahn Automotive Group(5) | 619 | 1,279 | 1,259 | ||
Operating Business Indicative Gross Asset Value | |||||
Add: Other Net Assets(6) | 98 | 67 | 103 | ||
Indicative Gross Asset Value | |||||
Add: Holding Company cash and cash equivalents(7) | 839 | 998 | 1,397 | ||
Less: Holding Company debt(7) | (4,664) | (4,663) | (4,699) | ||
Indicative Net Asset Value | |||||
Indicative net asset value does not purport to reflect a valuation of IEP. The calculated indicative net asset value does not include any value for our Investment Segment other than the fair market value of our investment in the Investment Funds. A valuation is a subjective exercise and indicative net asset value does not necessarily consider all elements or consider in the adequate proportion the elements that could affect the valuation of IEP. Investors may reasonably differ on what such elements are and their impact on IEP. No representation or assurance, express or implied, is made as to the accuracy and correctness of indicative net asset value as of these dates or with respect to any future indicative or prospective results which may vary.
(1) | Represents GAAP equity attributable to IEP as of each respective date. |
(2) | Based on closing share price on each date (or if such date was not a trading day, the immediately preceding trading day) and the number of shares owned by us as of each respective date. |
(3) | Amount based on market comparables due to lack of material trading volume, valued at 9.0x Adjusted EBITDA for the trailing twelve months ended as December 31, 2024. As of September 30, 2025, management no longer believed that the trailing twelve month Adjusted EBITDA, which had declined significantly and had been increasingly volatile, represented uniform performance and growth for the business or provides an accurate presentation of its value. For the periods ending September 30, 2025 and December 31, 2025, management performed a valuation of Viskase with the assistance of third-party consultants to estimate fair-market value. This analysis utilized the average results of a discounted cashflow methodology and a guideline public company methodology. Different judgments or assumptions would result in different estimates of value. Viskase indicative net asset value is derived by allocating our portion of ownership to the total equity value. |
(4) | For each period presented, management performed a valuation with the assistance of third-party consultants to estimate fair-market value, which utilized the average results of discounted cashflow and sales comparison methodologies. Different judgments or assumptions would result in different estimates of value. For certain properties under a purchase and sale agreement, indicative fair market value is based on the anticipated sales price adjusted for customary closing costs. In August 2025, certain properties were sold and as of September 30, 2025, the value of the consideration received and held in our Real Estate Segment consisted of preferred equity investment and debt and was used in the calculation of indicative fair value. |
(5) | For each period presented, management performed a valuation of Icahn Automotive Group ("IAG"), including the Automotive Services business and Automotive Owned Real Estate, with the assistance of third party consultants to estimate fair value. This analysis utilized the average results of a discounted cashflow methodology and a guideline public company methodology. Different judgments or assumptions would result in different estimates of value. During the fourth quarter of 2025 the majority of the Automotive Owned Real Estate was transferred to the Real Estate Segment and as of December 31, 2025 are now presented in the Real Estate Segment line item. The Automotive Owned Real Estate for the actual properties transferred was valued at |
(6) | Represents GAAP equity of the Holding Company Segment, excluding cash and cash equivalents, debt and non-cash deferred tax assets or liabilities. As of December 31, 2024, September 30, 2025, and December 31, 2025, Other Net Assets includes |
(7) | Holding Company's balance as of each respective date. |
Three Months Ended December 31, | Year Ended December 31, | ||||||
2025 | 2024 | 2025 | 2024 | ||||
(in millions)(unaudited) | |||||||
Adjusted EBITDA | |||||||
Net income (loss) | ( | ( | ( | ||||
Interest expense, net | 99 | 83 | 390 | 303 | |||
Income tax (benefit) | (27) | (23) | (19) | (25) | |||
Depreciation and amortization | 195 | 129 | 603 | 511 | |||
EBITDA before non-controlling interests | 311 | 79 | 648 | 247 | |||
Impairment | 28 | - | 40 | - | |||
Restructuring costs | 3 | 3 | 10 | 3 | |||
Loss (gain) on disposition of assets, net | 12 | (1) | (254) | 4 | |||
Transformation costs | 11 | 8 | 45 | 38 | |||
Loss (gain) on extinguishment of debt, net | 4 | - | - | (8) | |||
Gain on sale of equity method investment | - | (24) | - | (24) | |||
Gain on lease termination | - | (38) | - | (38) | |||
Same store adjustment including closing costs | 7 | 4 | 24 | 10 | |||
Other | 18 | 15 | 29 | 45 | |||
Adjusted EBITDA before non-controlling interests | |||||||
Adjusted EBITDA attributable to IEP | |||||||
Net income (loss) | ( | ( | ( | ||||
Interest expense, net | 87 | 72 | 344 | 263 | |||
Income tax (benefit) | (22) | (16) | (6) | (7) | |||
Depreciation and amortization | 134 | 83 | 409 | 336 | |||
EBITDA attributable to IEP | 200 | 41 | 448 | 147 | |||
Impairment | 28 | - | 39 | - | |||
Restructuring costs | 3 | 3 | 9 | 3 | |||
Loss (gain) on disposition of assets, net | 12 | (1) | (254) | 4 | |||
Transformation costs | 11 | 8 | 45 | 38 | |||
Loss (gain) on extinguishment of debt, net | 3 | - | (1) | (8) | |||
Gain on sale of equity method investment | - | (16) | - | (16) | |||
Gain on lease termination | - | (38) | - | (38) | |||
Same store adjustment including closing costs | 7 | 4 | 24 | 10 | |||
Other | 17 | 15 | 28 | 44 | |||
Adjusted EBITDA attributable to IEP | |||||||
Investor Contact:
Ted Papapostolou, Chief Financial Officer
IR@ielp.com
(800) 255-2737
View original content:https://www.prnewswire.com/news-releases/icahn-enterprises-lp-nasdaq-iep-today-announced-its-fourth-quarter-and-full-year-2025-financial-results-302696775.html
SOURCE Icahn Enterprises L.P.